Видео ютуба по тегу Brian I Rini

ТОП-3 основных моментов по теме #KidneyCancer с #ESMO25 от доктора Брайана Рини
ТОП-3 основных моментов по теме #KidneyCancer с #ESMO25 от доктора Брайана Рини
RCC Doublet Considerations: Immune-Mediated Toxicity, Duration of Treatment, and More
RCC Doublet Considerations: Immune-Mediated Toxicity, Duration of Treatment, and More
Prof. Brian Rini: From Transcriptomic Signatures to KIM-1
Prof. Brian Rini: From Transcriptomic Signatures to KIM-1
Видеоролик об исследовании OPTIC при раке почки, подготовленный доктором Брайаном Рини, и исследо...
Видеоролик об исследовании OPTIC при раке почки, подготовленный доктором Брайаном Рини, и исследо...
Adjuvant Therapy Considerations, According to Drs. Brian Rini and Monty Pal
Adjuvant Therapy Considerations, According to Drs. Brian Rini and Monty Pal
Dr. Brian Rini reviews the clear cell RCC landscape and forecasts 2025
Dr. Brian Rini reviews the clear cell RCC landscape and forecasts 2025
Brian Rini's criminal history
Brian Rini's criminal history
#KCRS19: Brian Rini, M D
#KCRS19: Brian Rini, M D
Brian I. Rini, MD, FACP, on how checkpoint inhibitors figure into treatment algorithms for RCC
Brian I. Rini, MD, FACP, on how checkpoint inhibitors figure into treatment algorithms for RCC
Brian Rini pleads not guilty
Brian Rini pleads not guilty
mRCC Metastatic Kidney Cancer: ASCO 2025 Immunotherapy Survival Breakthroughs | Dr. Brian Rini
mRCC Metastatic Kidney Cancer: ASCO 2025 Immunotherapy Survival Breakthroughs | Dr. Brian Rini
Brian Rini's Brother Says He Should Go To Prison For Impersonating Timmothy Pitzen
Brian Rini's Brother Says He Should Go To Prison For Impersonating Timmothy Pitzen
Brian Rini sentenced
Brian Rini sentenced
Brian Rini in court Friday
Brian Rini in court Friday
Brian I. Rini, MD, FACP, discusses the influence of the convenience of oral TKIs
Brian I. Rini, MD, FACP, discusses the influence of the convenience of oral TKIs
Dr. Brian Rini, Cleveland Clinic, USA
Dr. Brian Rini, Cleveland Clinic, USA
Brian I. Rini, MD, FACP, comments on the CARMENA study presented at ASCO 2018
Brian I. Rini, MD, FACP, comments on the CARMENA study presented at ASCO 2018
Phase 3 AXIS 1032 Trial Discussion with Brian I. Rini, MD
Phase 3 AXIS 1032 Trial Discussion with Brian I. Rini, MD
Brian Michael Rini Ordered Held Without Bail, Accused Of Lying To FBI In Timmothy Pitzen Hoax
Brian Michael Rini Ordered Held Without Bail, Accused Of Lying To FBI In Timmothy Pitzen Hoax
Brian I. Rini, MD, FACP, regarding the trade-offs between safety & efficacy in 1st line RCC
Brian I. Rini, MD, FACP, regarding the trade-offs between safety & efficacy in 1st line RCC
Brian Rini accused of impersonating Timmothy Pitzen, lying to federal agents
Brian Rini accused of impersonating Timmothy Pitzen, lying to federal agents
Brian I. Rini, MD, FACP, considers 2nd line treatment in advanced RCC following I-O failure
Brian I. Rini, MD, FACP, considers 2nd line treatment in advanced RCC following I-O failure
Rini Family Says Brian Rini Should Be Punished For Hoax
Rini Family Says Brian Rini Should Be Punished For Hoax
Brian Rini, man who said he was Timmothy Pitzen, faces federal charge
Brian Rini, man who said he was Timmothy Pitzen, faces federal charge
Brian I. Rini, MD, FACP, on which metastatic RCC patients should receive a TKI as 1st line therapy
Brian I. Rini, MD, FACP, on which metastatic RCC patients should receive a TKI as 1st line therapy